Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Denali Therapeutics Inc. Common Stock

DNLI Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of DNLI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
DNLI Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
DNLI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DNLI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in DNLI holdings by institutional investors

Quarterly net insider trading by DNLI's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for DNLI

Quiver Logo

No former government officials on record as having lobbied for DNLI

Revolving Door Dashboard

DNLI Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

DNLI Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
DNLI Income Statement
DNLI Balance Sheet
DNLI Cash Flow
U.S. Patents

New DNLI patent grants

  • Patent Title: Anti-her2 antibodies and methods of use thereof Aug. 11, 2026
  • Patent Title: Formulations of protein molecules comprising iduronate 2-sulfatase Jun. 30, 2026
  • Patent Title: Solid forms of a compound Jun. 23, 2026
  • Patent Title: Anti-transferrin receptor fusion proteins and methods of use thereof May. 26, 2026
  • Patent Title: Process for the preparation of pyrimidinyl-4-aminopyrazole compounds Dec. 16, 2025
  • Patent Title: Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof Aug. 05, 2025
  • Patent Title: Compounds, compositions and methods Jul. 15, 2025
  • Patent Title: Lrrk2 inhibitors and methods of making and using thereof Jul. 15, 2025
  • Patent Title: Anti-trem2 antibodies and methods of use thereof Mar. 04, 2025
  • Patent Title: Compounds, compositions and methods Dec. 31, 2024
  • Patent Title: Methods of engineering transferrin receptor binding polypeptides Dec. 10, 2024
  • Patent Title: Compounds, compositions and methods Nov. 12, 2024
  • Patent Title: Kinase inhibitors and uses thereof Oct. 29, 2024
  • Patent Title: Compounds, compositions and methods Sep. 17, 2024
  • Patent Title: Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide Jun. 04, 2024
  • Patent Title: Compounds, compositions and methods Apr. 16, 2024
  • Patent Title: Methods of engineering transferrin receptor binding polypeptides Feb. 27, 2024
  • Patent Title: Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof Jan. 30, 2024
  • Patent Title: Fusion proteins comprising enzyme replacement therapy enzymes Jan. 09, 2024
  • Patent Title: Modulators of eukaryotic initiation factor 2b, compositions and methods Dec. 26, 2023
  • Patent Title: Compounds, compositions and methods Dec. 26, 2023
  • Patent Title: Substituted pyrimidines as lrkk2 inhibitors Dec. 12, 2023
  • Patent Title: Compounds, compositions, and methods Dec. 05, 2023
  • Patent Title: Process for the preparation of pyrimidinyl-4-aminopyrazole compounds Dec. 05, 2023
  • Patent Title: Engineered transferrin receptor binding polypeptides Oct. 24, 2023
  • Patent Title: Anti-bace1 antibodies and methods of use thereof Oct. 03, 2023
  • Patent Title: Engineered polypeptides Aug. 22, 2023
  • Patent Title: Phospho-rab antibodies, assays and methods of use thereof May. 30, 2023
  • Patent Title: Progranulin variants May. 09, 2023
  • Patent Title: Transferrin receptor transgenic models Mar. 28, 2023
  • Patent Title: Compounds, compositions, and methods Feb. 28, 2023
  • Patent Title: Anti-tau antibodies and methods of use thereof Jun. 28, 2022
  • Patent Title: Compounds, compositions and methods Apr. 19, 2022
  • Patent Title: Modulators of eukaryotic initiation factor 2b, compositions and methods Feb. 01, 2022
  • Patent Title: Compound, compositions, and methods Jan. 04, 2022
  • Patent Title: Kinase inhibitors and uses thereof Dec. 21, 2021
  • Patent Title: Compounds, compositions and methods Nov. 16, 2021
  • Patent Title: Anti-trem2 antibodies and methods of use thereof Sep. 21, 2021
  • Patent Title: Compounds, compositions, and methods Sep. 07, 2021
  • Patent Title: Compounds, compositions and methods Jul. 27, 2021
  • Patent Title: Substituted pyrimidines as lrkk2 inhibitors Jun. 08, 2021
  • Patent Title: Fusion proteins comprising enzyme replacement therapy enzymes Dec. 22, 2020
  • Patent Title: Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production Dec. 01, 2020
  • Patent Title: Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (ripk1) Jul. 14, 2020
  • Patent Title: Compounds, compositions, and methods Mar. 17, 2020
  • Patent Title: Compounds, compositions, and methods Apr. 03, 2018
  • Patent Title: Compounds, compositions and methods Feb. 20, 2018
  • Patent Title: Compounds, compositions and methods Nov. 14, 2017
  • Patent Title: Oxadiazine compounds and methods of use thereof Oct. 31, 2017
  • Patent Title: Fused morpholinopyrimidines and methods of use thereof Sep. 26, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to DNLI from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
DNLI News

Recent insights relating to DNLI

CNBC Recommendations

Recent picks made for DNLI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DNLI

DNLI Analyst Ratings

DNLI Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
DNLI Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $DNLI stock a Buy, Sell, or Hold?

  • What is the price target for $DNLI stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

DNLI Top Shareholders
Shareholder
Shares Held
DNLI Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $DNLI stock?

  • Who owns the most shares of $DNLI stock?

  • What funds own $DNLI stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DNLI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DNLI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About DNLI

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

  • Address South San Francisco, CA
  • Market Cap 3.5 billion
  • Employees 507
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc. Common Stock (DNLI) Historical Stock Prices

Denali Therapeutics Inc. Common Stock (DNLI) closed at $21.60 on September 22, 2026. Over the past year its adjusted close ranged from $13.05 to $27.21. Daily prices go back to December 8, 2017, 2,207 trading days in all.

  • 1 month-13.32%
  • 3 months-12.80%
  • Year to date+30.83%
  • 1 year+62.16%
  • 3 years-2.48%
  • 5 years-59.17%
  • Max+0.70%
See every congressional and insider trade on the DNLI price chart

Quiver Premium charts DNLI's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 20.75 21.79 20.47 21.60 21.60 2,336,642
Sep 21, 2026 19.99 20.55 19.40 20.47 20.47 2,393,794
Sep 18, 2026 20.07 20.16 19.56 19.72 19.72 2,956,193
Sep 17, 2026 20.57 20.65 19.90 20.13 20.13 1,421,472
Sep 16, 2026 20.40 20.51 19.87 20.06 20.06 1,855,649
Sep 15, 2026 21.01 21.10 20.27 20.38 20.38 1,837,314
Sep 14, 2026 21.09 21.58 20.96 21.22 21.22 1,074,015
Sep 11, 2026 21.65 21.79 21.05 21.09 21.09 1,239,511
Sep 10, 2026 21.24 21.58 21.09 21.40 21.40 938,559
Sep 9, 2026 21.69 22.06 21.34 21.57 21.57 2,091,526
Sep 8, 2026 21.79 22.25 21.66 22.08 22.08 1,653,769
Sep 4, 2026 22.32 22.48 22.14 22.28 22.28 799,633
Sep 3, 2026 23.00 23.02 22.35 22.80 22.80 1,727,981
Sep 2, 2026 23.33 23.86 22.53 22.85 22.85 1,768,603
Sep 1, 2026 23.44 23.75 23.06 23.27 23.27 1,431,668
Aug 31, 2026 23.72 24.01 23.41 23.76 23.76 985,862
Aug 28, 2026 24.42 24.61 23.92 24.00 24.00 807,598
Aug 27, 2026 24.43 24.74 24.16 24.67 24.67 700,114
Aug 26, 2026 24.75 24.89 24.33 24.57 24.57 771,265
Aug 25, 2026 24.86 25.26 24.81 24.93 24.93 1,120,511
Aug 24, 2026 24.88 25.27 23.41 24.20 24.20 1,321,142
Aug 21, 2026 25.25 25.37 24.60 24.92 24.92 680,993
Aug 20, 2026 25.15 25.60 24.65 24.95 24.95 976,848
Aug 19, 2026 25.00 25.70 24.61 25.69 25.69 1,150,287
Aug 18, 2026 24.17 24.49 24.01 24.31 24.31 1,099,616
Aug 17, 2026 24.29 24.66 24.11 24.35 24.35 1,003,238
Aug 14, 2026 24.53 24.62 24.11 24.40 24.40 889,995
Aug 13, 2026 25.24 25.64 24.81 24.82 24.82 1,346,801
Aug 12, 2026 24.51 25.34 24.20 25.27 25.27 1,442,378
Aug 11, 2026 25.07 25.29 24.59 24.69 24.69 1,145,288
Aug 10, 2026 24.71 25.04 24.21 25.00 25.00 1,562,939
Aug 7, 2026 25.41 25.74 24.23 24.83 24.83 1,750,014
Aug 6, 2026 24.48 24.99 24.37 24.73 24.73 3,049,280
Aug 5, 2026 24.29 24.55 23.96 24.42 24.42 1,094,213
Aug 4, 2026 23.55 24.30 23.23 24.17 24.17 993,770
Aug 3, 2026 22.85 23.50 22.63 23.15 23.15 1,476,216
Jul 31, 2026 24.34 24.35 22.99 23.02 23.02 1,232,143
Jul 30, 2026 23.83 24.68 23.79 24.35 24.35 1,117,649
Jul 29, 2026 24.20 24.39 23.61 23.85 23.85 1,376,003
Jul 28, 2026 23.92 24.05 23.15 24.05 24.05 2,106,287
Jul 27, 2026 23.59 24.17 23.44 23.57 23.57 1,747,216
Jul 24, 2026 23.52 23.65 22.64 23.11 23.11 1,162,875
Jul 23, 2026 23.23 23.57 22.82 23.42 23.42 1,113,039
Jul 22, 2026 23.61 24.05 23.42 23.64 23.64 1,321,441
Jul 21, 2026 22.68 23.90 22.52 23.83 23.83 1,128,750
Jul 20, 2026 23.29 23.87 22.85 22.90 22.90 1,224,005
Jul 17, 2026 22.69 23.80 22.58 23.29 23.29 1,611,464
Jul 16, 2026 22.81 23.00 22.02 22.73 22.73 2,441,932
Jul 15, 2026 22.50 23.05 22.01 23.02 23.02 1,889,604
Jul 14, 2026 26.17 26.32 22.03 22.65 22.65 5,778,165
Jul 13, 2026 25.70 26.60 24.77 26.48 26.48 1,894,568
Jul 10, 2026 27.06 27.11 25.25 25.68 25.68 1,397,862
Jul 9, 2026 26.69 27.30 26.55 27.21 27.21 1,567,389
Jul 8, 2026 26.08 26.73 25.56 26.69 26.69 1,300,642
Jul 7, 2026 25.93 26.76 25.36 26.31 26.31 1,437,184
Jul 6, 2026 25.79 26.07 25.05 25.74 25.74 1,335,401
Jul 2, 2026 26.23 26.80 25.43 25.83 25.83 1,541,533
Jul 1, 2026 25.72 26.30 25.61 25.98 25.98 1,200,763
Jun 30, 2026 25.96 26.36 25.62 25.72 25.72 1,971,740
Jun 29, 2026 25.38 26.19 25.36 25.89 25.89 2,176,762
Jun 26, 2026 24.78 25.70 24.65 25.57 25.57 6,526,874
Jun 25, 2026 24.83 25.96 24.59 24.73 24.73 1,199,796
Jun 24, 2026 25.14 25.69 24.71 24.82 24.82 1,522,597
Jun 23, 2026 23.76 25.31 23.51 24.77 24.77 1,658,565
Jun 22, 2026 23.90 24.34 23.64 24.05 24.05 1,612,585
Jun 18, 2026 24.16 24.65 23.21 23.31 23.31 2,518,393
Jun 17, 2026 22.11 24.20 22.09 23.49 23.49 2,605,205
Jun 16, 2026 22.12 22.47 21.68 21.93 21.93 1,455,915
Jun 15, 2026 21.86 22.44 21.41 22.22 22.22 1,448,823
Jun 12, 2026 21.02 22.15 20.92 21.66 21.66 2,189,156
Jun 11, 2026 20.78 21.68 20.37 21.02 21.02 1,964,777
Jun 10, 2026 20.61 21.71 20.16 20.61 20.61 2,484,049
Jun 9, 2026 19.84 20.93 19.45 20.79 20.79 1,916,855
Jun 8, 2026 19.85 20.05 19.19 19.54 19.54 1,893,414
Jun 5, 2026 19.94 19.94 19.24 19.52 19.52 2,192,211
Jun 4, 2026 19.70 21.10 19.67 20.14 20.14 1,833,490
Jun 3, 2026 19.34 19.69 19.19 19.66 19.66 1,027,140
Jun 2, 2026 19.96 20.13 18.92 19.35 19.35 1,764,119
Jun 1, 2026 20.73 20.86 20.03 20.41 20.41 1,678,908
May 29, 2026 20.84 21.18 20.84 21.04 21.04 1,699,843
May 28, 2026 20.10 21.05 19.66 20.95 20.95 1,354,520
May 27, 2026 19.62 20.34 19.57 20.21 20.21 1,625,489
May 26, 2026 18.86 19.63 18.60 19.38 19.38 2,354,218
May 22, 2026 18.52 19.06 18.18 18.64 18.64 3,557,141
May 21, 2026 18.55 19.33 18.35 19.30 19.30 1,351,507
May 20, 2026 18.21 19.18 18.11 18.83 18.83 1,379,712
May 19, 2026 18.39 18.40 17.71 18.11 18.11 2,130,812
May 18, 2026 18.62 19.11 18.23 18.40 18.40 1,709,434
May 15, 2026 19.01 19.37 18.50 18.62 18.62 2,154,160
May 14, 2026 19.97 20.00 18.88 19.39 19.39 1,828,149
May 13, 2026 19.27 19.95 19.27 19.80 19.80 1,257,933
May 12, 2026 19.76 19.97 19.18 19.46 19.46 1,792,302
May 11, 2026 19.69 20.55 19.43 19.67 19.67 1,834,085
May 8, 2026 19.44 20.53 19.44 19.62 19.62 1,945,846
May 7, 2026 20.40 20.41 19.19 19.71 19.71 1,228,531
May 6, 2026 19.22 20.49 18.91 20.41 20.41 2,199,216
May 5, 2026 18.99 19.40 18.33 18.92 18.92 2,535,662
May 4, 2026 18.14 19.15 18.10 18.67 18.67 2,481,927
May 1, 2026 18.70 18.81 18.21 18.30 18.30 1,514,442
Apr 30, 2026 18.69 18.92 18.33 18.72 18.72 2,866,551
Apr 29, 2026 19.60 20.17 18.23 18.60 18.60 3,000,027
Apr 28, 2026 19.97 20.43 19.84 20.06 20.06 1,082,248
Apr 27, 2026 19.76 20.36 19.76 19.94 19.94 1,030,313
Apr 24, 2026 19.45 20.05 19.27 19.87 19.87 1,174,238
Apr 23, 2026 20.28 20.36 19.20 19.45 19.45 1,221,096
Apr 22, 2026 20.28 20.57 20.00 20.25 20.25 1,424,881
Apr 21, 2026 20.50 20.75 19.94 20.13 20.13 1,026,006
Apr 20, 2026 20.76 20.88 20.09 20.54 20.54 738,986
Apr 17, 2026 21.13 21.37 20.54 20.57 20.57 1,462,091
Apr 16, 2026 21.63 21.80 20.64 20.71 20.71 1,515,701
Apr 15, 2026 20.24 21.71 20.20 21.68 21.68 1,877,465
Apr 14, 2026 19.43 20.29 19.43 20.16 20.16 807,162
Apr 13, 2026 19.23 19.93 19.02 19.42 19.42 1,107,729
Apr 10, 2026 19.41 19.63 18.96 19.23 19.23 1,127,304
Apr 9, 2026 19.37 19.73 19.05 19.29 19.29 1,435,511
Apr 8, 2026 20.04 20.29 19.26 19.62 19.62 1,116,425
Apr 7, 2026 19.23 19.53 18.80 19.41 19.41 1,197,073
Apr 6, 2026 20.60 20.80 19.22 19.38 19.38 1,801,194
Apr 2, 2026 18.92 20.66 18.92 20.65 20.65 1,625,806
Apr 1, 2026 19.56 20.00 19.33 19.68 19.68 1,912,412
Mar 31, 2026 18.90 19.44 18.74 19.20 19.20 2,216,434
Mar 30, 2026 18.26 18.46 17.86 18.08 18.08 1,733,974
Mar 27, 2026 19.59 19.74 18.10 18.16 18.16 3,068,890
Mar 26, 2026 22.53 22.58 19.73 19.73 19.73 3,426,129
Mar 25, 2026 22.62 23.46 21.27 22.47 22.47 5,408,026
Mar 24, 2026 20.73 21.21 20.54 20.97 20.97 1,627,499
Mar 23, 2026 20.75 21.66 20.50 21.09 21.09 1,663,702
Mar 20, 2026 19.74 20.51 19.63 20.17 20.17 3,892,145
Mar 19, 2026 19.88 20.19 18.93 19.75 19.75 1,381,525
Mar 18, 2026 20.51 20.66 19.90 20.06 20.06 1,081,095
Mar 17, 2026 20.53 20.90 20.45 20.71 20.71 1,177,957
Mar 16, 2026 20.54 21.16 20.31 20.57 20.57 1,454,860
Mar 13, 2026 20.91 21.42 20.08 20.57 20.57 1,290,238
Mar 12, 2026 21.03 21.53 20.00 20.70 20.70 1,329,779
Mar 11, 2026 21.46 21.72 20.82 21.61 21.61 1,140,945
Mar 10, 2026 21.31 21.82 21.09 21.43 21.43 2,016,401
Mar 9, 2026 20.32 21.75 20.17 21.31 21.31 2,627,260
Mar 6, 2026 19.46 19.76 19.05 19.69 19.69 1,260,862
Mar 5, 2026 19.93 20.63 19.45 19.70 19.70 1,453,298
Mar 4, 2026 20.29 20.92 19.94 20.37 20.37 1,249,589
Mar 3, 2026 20.18 20.64 19.76 20.02 20.02 1,357,536
Mar 2, 2026 21.14 21.52 20.58 21.00 21.00 1,420,159
Feb 27, 2026 21.14 21.45 20.25 21.18 21.18 1,411,732
Feb 26, 2026 22.20 22.39 21.00 21.42 21.42 1,655,546
Feb 25, 2026 21.60 22.59 21.60 22.29 22.29 1,702,069
Feb 24, 2026 20.86 21.56 20.48 21.43 21.43 1,432,087
Feb 23, 2026 20.30 21.38 20.10 20.86 20.86 1,429,304
Feb 20, 2026 20.00 20.51 19.69 20.19 20.19 1,798,754
Feb 19, 2026 19.08 20.36 18.96 20.24 20.24 1,613,252
Feb 18, 2026 19.01 20.01 19.00 19.23 19.23 2,629,616
Feb 17, 2026 18.73 19.63 18.65 19.28 19.28 1,858,787
Feb 13, 2026 19.24 20.12 18.61 18.77 18.77 1,343,401
Feb 12, 2026 19.81 20.21 18.75 19.18 19.18 1,397,305
Feb 11, 2026 19.91 20.00 18.66 19.69 19.69 1,463,370
Feb 10, 2026 21.05 21.15 19.74 19.82 19.82 2,000,628
Feb 9, 2026 21.20 21.20 20.16 20.84 20.84 1,250,704
Feb 6, 2026 20.40 21.31 20.36 21.08 21.08 1,648,342
Feb 5, 2026 21.16 21.48 19.76 20.02 20.02 1,627,017
Feb 4, 2026 21.98 21.98 20.64 21.28 21.28 1,832,699
Feb 3, 2026 22.89 23.77 21.32 21.78 21.78 1,727,856
Feb 2, 2026 21.33 22.78 21.13 22.74 22.74 1,594,320
Jan 30, 2026 21.37 22.00 21.13 21.74 21.74 2,748,758
Jan 29, 2026 21.36 21.99 20.67 21.59 21.59 1,496,377
Jan 28, 2026 21.43 21.81 20.35 20.84 20.84 2,632,988
Jan 27, 2026 20.64 21.34 20.36 21.25 21.25 1,448,863
Jan 26, 2026 20.01 21.14 19.56 20.61 20.61 1,538,526
Jan 23, 2026 20.82 21.39 20.17 20.25 20.25 2,103,371
Jan 22, 2026 18.74 21.09 18.67 20.93 20.93 3,088,389
Jan 21, 2026 17.52 18.79 17.52 18.60 18.60 1,845,921
Jan 20, 2026 17.42 17.80 17.18 17.53 17.53 1,414,267
Jan 16, 2026 19.12 19.14 17.90 17.99 17.99 1,386,339
Jan 15, 2026 18.25 18.98 17.88 18.78 18.78 1,894,543
Jan 14, 2026 18.09 18.48 17.94 18.27 18.27 1,128,570
Jan 13, 2026 17.98 18.18 17.64 18.11 18.11 1,225,568
Jan 12, 2026 17.25 17.98 16.96 17.95 17.95 1,144,672
Jan 9, 2026 17.39 17.71 17.03 17.08 17.08 987,124
Jan 8, 2026 16.98 17.57 16.64 17.07 17.07 1,757,427
Jan 7, 2026 17.48 17.95 16.70 16.95 16.95 1,877,134
Jan 6, 2026 16.13 17.25 16.00 17.21 17.21 2,779,172
Jan 5, 2026 16.20 16.53 15.34 16.02 16.02 1,628,321
Jan 2, 2026 16.66 16.68 15.69 16.27 16.27 1,185,505
Dec 31, 2025 16.42 16.67 16.28 16.51 16.51 1,159,499
Dec 30, 2025 16.51 16.66 16.34 16.41 16.41 851,898
Dec 29, 2025 16.70 16.91 16.44 16.58 16.58 1,264,038
Dec 26, 2025 16.92 16.93 16.55 16.87 16.87 677,996
Dec 24, 2025 16.90 17.05 16.72 16.99 16.99 505,006
Dec 23, 2025 17.43 17.61 16.72 16.81 16.81 1,057,264
Dec 22, 2025 16.90 17.85 16.81 17.47 17.47 1,419,889
Dec 19, 2025 16.84 17.30 16.81 16.85 16.85 2,144,977
Dec 18, 2025 16.94 17.28 16.74 16.77 16.77 945,046
Dec 17, 2025 16.96 17.30 16.66 16.81 16.81 1,249,194
Dec 16, 2025 17.40 17.55 16.82 17.02 17.02 1,709,223
Dec 15, 2025 18.14 18.17 17.22 17.34 17.34 1,774,148
Dec 12, 2025 17.41 18.30 17.24 17.98 17.98 1,400,507
Dec 11, 2025 17.37 17.76 17.20 17.37 17.37 2,999,115
Dec 10, 2025 18.30 19.59 17.52 17.57 17.57 6,063,669
Dec 9, 2025 19.62 19.87 19.19 19.66 19.66 1,356,065
Dec 8, 2025 20.23 20.57 19.50 19.69 19.69 1,480,858
Dec 5, 2025 20.37 20.61 19.94 19.96 19.96 2,022,030
Dec 4, 2025 18.77 20.48 18.47 20.11 20.11 2,536,997
Dec 3, 2025 18.03 19.16 17.90 19.00 19.00 1,474,308
Dec 2, 2025 18.22 18.48 17.65 17.84 17.84 1,192,630
Dec 1, 2025 19.10 19.13 18.00 18.16 18.16 1,570,764
Nov 28, 2025 19.46 19.53 18.95 19.47 19.47 1,088,610
Nov 26, 2025 19.10 19.57 18.74 19.40 19.40 983,973
Nov 25, 2025 18.97 19.63 18.88 19.13 19.13 1,284,884
Nov 24, 2025 18.12 19.00 18.03 18.93 18.93 1,914,081
Nov 21, 2025 16.93 18.23 16.87 18.00 18.00 1,449,649
Nov 20, 2025 16.96 17.95 16.87 17.16 17.16 1,411,508
Nov 19, 2025 17.36 17.60 16.85 16.92 16.92 1,623,988
Nov 18, 2025 17.25 17.65 16.93 17.48 17.48 903,348
Nov 17, 2025 17.40 17.83 17.25 17.37 17.37 1,115,545
Nov 14, 2025 16.79 18.21 16.78 17.44 17.44 1,281,104
Nov 13, 2025 17.23 17.84 16.66 17.15 17.15 1,421,686
Nov 12, 2025 17.59 18.70 17.17 17.52 17.52 1,897,628
Nov 11, 2025 15.58 17.68 15.18 17.58 17.58 2,042,440
Nov 10, 2025 15.42 16.55 15.32 15.60 15.60 1,923,464
Nov 7, 2025 14.55 15.22 13.75 15.02 15.02 2,056,348
Nov 6, 2025 14.82 15.10 14.30 14.41 14.41 1,181,420
Nov 5, 2025 14.84 14.99 14.56 14.89 14.89 1,247,353
Nov 4, 2025 15.10 15.29 14.83 14.92 14.92 1,047,974
Nov 3, 2025 15.98 16.33 15.00 15.36 15.36 1,542,705
Oct 31, 2025 16.25 16.45 15.90 16.28 16.28 1,235,867
Oct 30, 2025 16.00 16.98 16.00 16.38 16.38 1,605,139
Oct 29, 2025 16.79 16.98 16.04 16.25 16.25 1,262,674
Oct 28, 2025 16.37 17.02 16.04 16.92 16.92 1,504,956
Oct 27, 2025 16.17 16.78 16.12 16.21 16.21 1,488,747
Oct 24, 2025 16.00 16.41 15.89 15.96 15.96 1,073,993
Oct 23, 2025 15.86 16.09 15.53 15.88 15.88 1,403,214
Oct 22, 2025 16.97 17.26 15.92 15.95 15.95 1,638,992
Oct 21, 2025 17.33 17.40 16.85 16.96 16.96 1,207,511
Oct 20, 2025 16.97 17.72 16.91 17.25 17.25 1,556,304
Oct 17, 2025 16.44 16.80 16.23 16.66 16.66 1,365,791
Oct 16, 2025 16.49 17.39 16.30 16.72 16.72 2,568,366
Oct 15, 2025 15.23 16.43 15.19 16.31 16.31 1,714,755
Oct 14, 2025 14.51 15.29 14.02 15.21 15.21 2,634,211
Oct 13, 2025 15.42 15.62 14.98 14.98 14.98 1,231,879
Oct 10, 2025 16.20 16.51 15.00 15.37 15.37 1,749,554
Oct 9, 2025 15.66 16.50 15.66 16.17 16.17 1,610,699
Oct 8, 2025 15.00 16.12 14.89 15.65 15.65 1,843,151
Oct 7, 2025 15.36 15.40 14.85 14.90 14.90 1,275,840
Oct 6, 2025 15.40 15.44 15.05 15.22 15.22 1,673,571
Oct 3, 2025 15.31 15.75 15.19 15.42 15.42 1,423,623
Oct 2, 2025 15.45 15.68 14.90 15.20 15.20 1,613,437
Oct 1, 2025 14.69 15.75 14.58 14.91 14.91 2,175,241
Sep 30, 2025 14.48 14.58 14.08 14.52 14.52 2,092,302
Sep 29, 2025 14.15 14.56 13.88 14.52 14.52 2,199,117
Sep 26, 2025 13.50 14.07 13.28 13.95 13.95 2,327,634
Sep 25, 2025 13.40 13.60 13.14 13.43 13.43 2,231,053
Sep 24, 2025 13.04 13.65 13.00 13.48 13.48 2,286,855
Sep 23, 2025 13.34 13.42 12.78 13.05 13.05 2,341,925
Sep 22, 2025 12.80 13.59 12.58 13.32 13.32 2,282,593

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Denali Therapeutics Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at DNLI, per a recent SEC DEF 14A filing. We estimate that the median employee at Denali Therapeutics Inc. is paid $347,840.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation